510(k) device
V8 Balloon Aortic Valvuloplasty Catheter
Intervalve, Inc. · Balloon Aortic Valvuloplasty (OZT, Class II) · First FDA decision Dec 18, 2015, newest Dec 18, 2015Aortic stenosis
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
5
Naming "V8"
MAUDE reports
60
Brand "V8", since 2015
PubMed studies
4,524
Mentioning "V8"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing V8 Balloon Aortic Valvuloplasty Catheter
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K152150 · Decided Dec 18, 2015 · 137 days after receipt
Device type: Balloon Aortic Valvuloplasty (OZT) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Blood Counts (Addition of ICD-9-CM Codes V77.1, V81.0, V81.1, and V81.2 to the list of Codes that Do Not Support Medical Necessity)Coding analysisReview closedCAG-00285NUpdated Sep 14, 2026
Clinical trials
Device studies on ClinicalTrials.gov that name "V8", any status and sponsor, newest update first.
Jonathan Schoenfeld, MD, MPHAcademic, hospital or other
NCT04900623 · 145 participants (planned) · Start Jul 2, 2021 · Primary completion Jun 1, 2030
Device: NavDx HPV ctDNA Testing · For: HPV-Associated Oropharyngeal Squamous Cell Carcinoma; HPV Positive Oropharyngeal Squamous Cell Carcinoma; HPV-Mediated (P16-Positive) Oropharyngeal Carcinoma by AJCC V8 Stage and 9 more
Sites: Boston, Massachusetts · 2 sites in all
4 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "V8", and for the whole product code for context.
This brand
60 reports: 58 malfunction, 0 injury, 2 death
Whole product code OZT
356 reports: 223 malfunction, 102 injury, 27 death
Newest reports for this brand
- 8300 ETCO2 MODULE, V8Malfunction
2016493-2021-511282 · Received Jul 29, 2021
Device type: Analyzer, Gas, Carbon-Dioxide, Gaseous-Phase (CCK)
Device problem as coded: No Apparent Adverse Event
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "V8"[tiab]. The summary above synthesizes these.
- S. aureus drives itch and scratch-induced skin damage through a V8 protease-PAR1 axis.
Deng L, Costa F, Blake KJ, et al. · Cell · 2023Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural
- Staphylococcus scratches its itch.
Major J, Naik S · Cell · 2023
- V8, a lysosomotropic wogonin derivative, alleviates hepatic steatosis by modulating GDF15-dependent mitochondrial homeostasis.
Li S, Shao S, Zhang Z, et al. · Free Radic Biol Med · 2026
- Urinary incontinence in female university students.
Ural ÜM, Gücük S, Ekici A, et al. · Int Urogynecol J · 2021
- Mediterranean Diet and Overactive Bladder.
Bozkurt YE, Temeltaş G, Müezzinoğlu T, et al. · Int Neurourol J · 2022
- Polypoid Lesion Segmentation Using YOLO-V8 Network in Wireless Video Capsule Endoscopy Images.
Sahafi A, Koulaouzidis A, Lalinia M · Diagnostics (Basel) · 2024
- Identification of a novel spirocyclic Nek2 inhibitor using high throughput virtual screening.
Bhuiyan AI, Choi AH, Ghoshal S, et al. · Bioorg Med Chem Lett · 2023Research Support, N.I.H., Extramural
- Enhancers of the PAIR4 regulatory module promote distal VH gene recombination at the Igh locus.
Hill L, Jaritz M, Tagoh H, et al. · EMBO J · 2023Research Support, Non-U.S. Gov't
- Methods for Brain Atrophy MR Quantification in Multiple Sclerosis: Application to the Multicenter INNI Dataset.
Storelli L, Pagani E, Pantano P, et al. · J Magn Reson Imaging · 2023Multicenter Study, Research Support, Non-U.S. Gov't
- DIANA-TarBase v8: a decade-long collection of experimentally supported miRNA-gene interactions.
Karagkouni D, Paraskevopoulou MD, Chatzopoulos S, et al. · Nucleic Acids Res · 2018Research Support, Non-U.S. Gov't
- Enhancing Microcalcification Detection in Mammography with YOLO-v8 Performance and Clinical Implications.
Shia WC, Ku TH · Diagnostics (Basel) · 2024
- Usefulness of leads V7, V8, and V9 ST elevation to diagnose isolated posterior myocardial infarction.
Wong CK · Int J Cardiol · 2011Letter, Research Support, Non-U.S. Gov't
Other devices of this type
Also filed under product code OZT.
- V8 Transluminal BAV CatheterIntervalve, Inc. · 510(k) 2015
- True Flow Valvuloplasty Perfusion CatheterC.R. Bard, Inc. · 510(k) 2017
- ValvuloPro Valvuloplasty Balloon CatheterDongguan TT Medical, Inc. · 510(k) 2024
- KardiaPSI Balloon CatheterIntervention Tech, Inc. · 510(k) 2026
- Valvuloplasty Balloon Catheter (ValvuloPro)Dongguan TT Medical, Inc. · 510(k) 2026
- OutFlo Aortic Valve Dilatation Balloon CatheterDisa Medinotec · 510(k) 2025
- Inoue Balloon aToray Industries, Inc. · 510(k) 2022
- True Dilatation Balloon Valvuloplasty CatheterC.R. Bard, Inc. · 510(k) 2015
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.